Carasent

Q2 2026 highlights

• Net sales amounted to SEK 97.7 (82.9) million, corresponding to a net sales growth of 18%.
• Organic growth amounted to 11% at constant currency.
• EBITDA amounted to SEK 14.8 (12.1) million, corresponding to an EBITDA margin of 15% (15%).
• Adjusted EBITDA margin was 19% (15%).
• Adjusted EBITDAC margin was 11% (3%).
• Operating result, EBIT, amounted to SEK -2.7 (-3.7) million.
• Cash flow from operating activities amounted to SEK 25.4 (12.8) million.
• Profit after tax amounted to SEK -2.8 million (-5.5).
• Earnings per share, before and after dilution, amounted to SEK -0.04 (-0.08).

H1 2026 highlights

• Net sales amounted to SEK 188.1 (168.1) million, corresponding to a net sales growth of 12%.
• Organic growth amounted to 9% at constant currency.
• EBITDA amounted to SEK 33.0 (26.0) million, corresponding to an EBITDA margin of 18% (15%).
• Adjusted EBITDA margin was 20% (15%).
• Adjusted EBITDAC margin was 10% (4%).
• Operating result amounted to SEK -1.1 million (-5.6).
• Cash flow from operating activities amounted to SEK 68.3 million (17.4).
• Profit after tax amounted to SEK 0.2 million (-8.5).
• Earnings per share, before and after dilution, amounted to SEK 0.00 (-0.12).

Carasent will host a presentation of the report as a webcast today at 08:00 CET. If you wish to participate via webcast, please use the link below:
Carasent Q2 Report 2026

For further details please contact:
Daniel Öhman, CEO Tel: +46 70-855 37 07, or
Svein Martin Bjørnstad, CFO Tel: +47 979 69 493